On, J.L.; Ghaderi, S.; Rittmann, C.; Hoffmann, G.; Gier, F.; Woloschin, V.; Tu, J.-W.; Bhatia, S.; Kulik, A.; Niederacher, D.;
et al. Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2025, 26, 1078.
https://doi.org/10.3390/ijms26031078
AMA Style
On JL, Ghaderi S, Rittmann C, Hoffmann G, Gier F, Woloschin V, Tu J-W, Bhatia S, Kulik A, Niederacher D,
et al. Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2025; 26(3):1078.
https://doi.org/10.3390/ijms26031078
Chicago/Turabian Style
On, Jasmin Linh, Sahel Ghaderi, Carina Rittmann, Greta Hoffmann, Franziska Gier, Vitalij Woloschin, Jia-Wey Tu, Sanil Bhatia, Andrea Kulik, Dieter Niederacher,
and et al. 2025. "Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast Cancer" International Journal of Molecular Sciences 26, no. 3: 1078.
https://doi.org/10.3390/ijms26031078
APA Style
On, J. L., Ghaderi, S., Rittmann, C., Hoffmann, G., Gier, F., Woloschin, V., Tu, J.-W., Bhatia, S., Kulik, A., Niederacher, D., Neubauer, H., Kurz, T., Fehm, T., & Esser, K.
(2025). Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast Cancer. International Journal of Molecular Sciences, 26(3), 1078.
https://doi.org/10.3390/ijms26031078